Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) has launched its first direct-to-consumer ad for ZORYVE cream, a once-daily, steroid-free treatment for plaque psoriasis. The ad campaign, titled 'The Cream That Can', aims to highlight the benefits of ZORYVE, which is included on all three of the largest pharmacy benefit managers in the US, providing access to 80% of covered commercial lives without prior authorization.